Home | Current Issue | Past Issues | Search | CollectionsRSS | PDA Services | FAQ | SHCIM Online | Chinese Updated Wednesday, September 17, 2014
 Services
Submit a manuscript
Subscribe
Individuals
Institutions
Response
Send response
Read responses
Reprint
Advance online publication
Sign up for e-alert
JCIM job opportunities
Contact JCIM
 Information For
Readers
Authors
Reviewers
Advertisers
 About JCIM
Journal description
Editorial policy
Privacy policy
Copy right
Editorial staff
 Language Polishing
Journal of Chinese Integrative Medicine: 2011; 9(12): 1312-1318
DOI: 10.3736/jcim20111206
Bufei Yishen Granule combined with acupoint-sticking therapy in patients with stable chronic obstructive pulmonary disease: study protocol of a multicenter, randomized, double-blind, active-controlled trial
1. Jian-sheng Li (Institute of Geriatrics, Henan University of Traditional Chinese Medicine, Zhengzhou 450008, Henan Province, China )
2. Su-yun Li (Department of Respiratory Diseases, the First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou 450000, Henan Province, China )
3. Xue-qing Yu (Department of Respiratory Diseases, the First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou 450000, Henan Province, China )
4. Yang Xie (Institute of Geriatrics, Henan University of Traditional Chinese Medicine, Zhengzhou 450008, Henan Province, China )
Background: Chronic obstructive pulmonary disease (COPD) is a serious disease constituting a major threat to public health. Current popularity of traditional Chinese medicine (TCM) in treating COPD implies its potential advantage in improving symptoms, reducing the frequency of acute exacerbation and improving the patients' quality of life. This study is to evaluate the efficacy and safety of a comprehensive intervention, Bufei Yishen Granule combined with acupoint-sticking therapy, in patients with stable COPD.
Methods and design: A multicenter, double-blind, double-dummy and randomized controlled design will be adopted. A total of 244 cases meeting the inclusion criteria will be enrolled into this study with 122 cases in the trial group and 122 in the control group, respectively. Patients in the trial group will receive Bufei Yishen Granule combined with acupoint-sticking therapy and dummy sustained-release theophylline, while patients in the control group will receive sustained-release theophylline and dummy Bufei Yishen Granule combined with dummy acupoint-sticking therapy. The frequency and duration of acute exacerbation, lung function, clinical symptoms, six-minute walking distance, dyspnea grade and quality of life will be observed during a four-month treatment period and a further six-month follow-up.
Discussion: It is hypothesized that Bufei Yishen Granule combined with acupoint-sticking therapy will have beneficial effects in reducing the frequency and duration of acute exacerbation, ameliorating the symptoms, and improving the quality of life of patients with stable COPD. The results of this study will provide evidence for developing a TCM-based regimen for patients with COPD.
Trial registration: ChiCTR-TRC-11001409.
Welcome to JCIM! You are the number 3662 reader of this article!
Download Article:
[Full Text]      [PDF]      [Chinese]      [Previous]      [Next]      [This Issue]
Please cite this article as:
Li JS, Li SY, Yu XQ, Xie Y. Bufei Yishen Granule combined with acupoint-sticking therapy in patients with stable chronic obstructive pulmonary disease: study protocol of a multicenter, randomized, double-blind, active-controlled trial. J Chin Integr Med / Zhong Xi Yi Jie He Xue Bao. 2011; 9(12): 1312-1318.
References:
1Zhong N, Wang C, Yao W, Chen P, Kang J, Huang S, Chen B, Wang C, Ni D, Zhou Y, Liu S, Wang X, Wang D, Lu J, Zheng J, Ran P. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey[J].Am J Respir Crit Care Med, 2007, 176(8): 753-760.  .
2Lin HH, Murray M, Cohen T, Colijn C, Ezzati M. Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study[J].Lancet, 2008, 372(9648): 1473-1483.  .
3Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J; TORCH investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease[J].N Engl J Med, 2007, 356(8): 775-789.  .
4Li JS, Wang ZW, Yu XQ, Wang MH, Li SY. Clinical efficacy and safety of TCM for COPD at stable phase: a systematic review[J].Liaoning Zhong Yi Za Zhi, 2010, 37(2): 229-232. Chinese with abstract in English.
5Li JS, Wang ZW, Yu XQ, Wang MH, Li SY. Systemic evaluation of TCM for COPD in the acute stage of exacerbation[J].Tianjin Zhong Yi Yao, 2008, 25(5): 428-432. Chinese with abstract in English.
6Li SY, Zhou QW, Wang MH, Wang HF, Wu JZ. Effect of Bufei Yishen granule on pulmonary ventilation function and immunological function of patients with chronic obstructive pulmonary disease in remission phase: a randomized grouping and placebo controlled study[J].Zhongguo Lin Chuang Kang Fu, 2006, 10(7): 145-147. Chinese.
7Li SY, Li JS, Yu XQ, Zhou QW, Wang XY. Clinical observation of Shu-Fei Tie acupoint-sticking therapy in the treatment of patients with chronic obstructive pulmonary disease[J].Shannxi Zhong Yi, 2009, 30(4): 391-392. Chinese.
8Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS; GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary[J].Am J Respir Crit Care Med, 2001, 163(5): 1256-1276.  .
9COPD Group of Chinese Society of Respiratory Diseases. Guidelines for the diagnosis and treatment of chronic obstructive pulmonary disease (2007 revised edition)[J].Zhonghua Jie He He Hu Xi Za Zhi, 2007, 30(1): 8-17. Chinese.
10Wang ZW, Li JS, Yu XQ, Wang MH, Li SY. Symptom diagnosis criteria for chronic obstructive pulmonary diseases at stationary phase based on literature[J].Zhong Yi Yan Jiu, 2008, 21(8): 55-58. Chinese.
11Zhou Y, Wang X, Zeng X, Qiu R, Xie J, Liu S, Zheng J, Zhong N, Ran P. Positive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 year[J].Respirology, 2006, 11(5): 603-610.  .
12Fletcher CM, Elmes PC, Fairbairn MB, Wood CH. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population[J].Br Med J, 1959, 2(5147): 257-266.  .
13Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea[J].Chest, 1988, 93(3): 580-586.  .
14World Health Organization. The World Health Organization Quality of Life (WHOQOL)-BREF. Geneva: World Health Organization. 2004.
15Cai YY, Li ZZ, Fang ZJ. Evaluation of the quality of life of chronic obstructive pulmonary disease patients[J].Zhonghua Quan Ke Yi Shi Za Zhi, 2004, 3(4): 225-227. Chinese.
16ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test[J].Am J Respir Crit Care Med, 2002, 166(1): 111-117.  .
17Zhang WJ, Zhang YP. Recent research progress in traditional Chinese medicine treatment of chronic obstructive pulmonary disease[J].Beijing Zhong Yi Yao Da Xue Xue Bao Zhong Yi Lin Chuang Ban, 2007, 14(5): 39-41. Chinese.
18Molfino NA, Zhang P. A meta-analysis on the efficacy of oral theophylline in patients with stable COPD[J].Int J Chron Obstruct Pulmon Dis, 2006, 1(3): 261-266.  .
19Li JS, Wang MH, Li SY. Appraisal investigating progress of chronic obstructive pulmonary dyspnea[J].Henan Zhong Yi Xue Yuan Xue Bao, 2007, 22(2): 79-82. Chinese.
20Montes de Oca M, Torres SH, González Y, Romero E, Hernández N, Tálamo C. Changes in exercise tolerance, health related quality of life, and peripheral muscle characteristics of chronic obstructive pulmonary disease patients after 6 weeks' training[J].Arch Bronconeumol, 2005, 41(8): 413-418.  .

 Home | Current Issue | Past Issues | Search | CollectionsRSS | PDA Services | FAQ | SHCIM Online | Chinese
Copyright © 2003-2012 by JCIM Press. All rights reserved. ISSN 1672-1977